Speed to Market

Sinclair Research understands the pressure clients are under to meet IND and NDA milestones and goals in the overall regulatory drug and device development process. Our rapid study initiation and expedited reporting support the overall goal of clients achieving early market approvals. Our device group in particular, including our biocompatibility testing, is very responsive for study turnaround.

 

Translate »